SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-14-430243
Filing Date
2014-12-02
Accepted
2014-12-02 09:17:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14D-9C d831222dsc14d9c.htm SC14D9C 12418
  Complete submission text file 0001193125-14-430243.txt   14399
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filed by) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Subject) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC14D9C | Act: 34 | File No.: 005-41430 | Film No.: 141259381
SIC: 2834 Pharmaceutical Preparations